TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biotechst Lund AB
Closing information (x1000 EUR)
Closing information | 2022/08 | 2021/08 | 2020/08 |
Turnover | 75 | 69 | 69 |
Financial expenses | 0 | 0 | 0 |
Earnings before taxes | 7 | 1 | 0 |
EBITDA | 7 | 1 | 0 |
Total assets | 47 | 43 | 41 |
Current assets | 47 | 43 | 41 |
Current liabilities | 16 | 17 | 16 |
Equity capital | 31 | 27 | 25 |
- share capital | 9 | 10 | 10 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2022/08 | 2021/08 | 2020/08 |
Solvency | 66.0% | 62.8% | 61.0% |
Turnover per employee | 75 | 69 | 69 |
Profit as a percentage of turnover | 9.3% | 1.4% | 0% |
Return on assets (ROA) | 14.9% | 2.3% | 0% |
Current ratio | 293.8% | 252.9% | 256.2% |
Return on equity (ROE) | 22.6% | 3.7% | 0% |
Change turnover | 10 | -1 | -6 |
Change turnover % | 15% | -1% | -8% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/08 | 2021/08 | 2020/08 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.